Keapstone Therapeutics
PrivateLast Round
Seed
Sep 24, 2018
Total Funding Raised
$2.5M
Company Overview
Keapstone Therapeutics operates in Healthcare & Life Sciences and is based in Sheffield. Its latest recorded funding round was a Seed round in September 2018.
Keapstone Therapeutics is a drug discovery company developing a new class of highly-specific medicines that target the Keap1-Nrf2 protein-protein interaction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Keapstone Therapeutics Comparables
Compare Keapstone Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| vTv Therapeutics Inc | 74% | |
| Bayer AG | 72% | |
| C4X Discovery Holdings plc | 70% |
For institutional investors. Book with your work email.
Keapstone Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 24, 2018 | ||||
| Seed | Mar 8, 2017 |
For institutional investors. Book with your work email.
Keapstone Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Parkinson's UK | Seed |
| The University of Sheffield | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors grew 280% MoM, reaching 1.9K.
- Mar 1, 2026
Monthly visitors grew 107% MoM.
For institutional investors. Book with your work email.
Keapstone Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Keapstone Therapeutics's valuation, stock price, and market status.
Is Keapstone Therapeutics a public or private company?
Keapstone Therapeutics is a private company.
What is the current stock price of Keapstone Therapeutics?
Keapstone Therapeutics is a private company, so its shares have no public market price. Caplight tracks Keapstone Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Keapstone Therapeutics worth (valuation)?
Valuation information for Keapstone Therapeutics is not publicly available.
Can I buy Keapstone Therapeutics stock?
Keapstone Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Keapstone Therapeutics's last funding round?
Keapstone Therapeutics's most recent funding round was Seed on September 24, 2018.
Who are the main investors in Keapstone Therapeutics?
Key investors in Keapstone Therapeutics include Parkinson's UK.
Will Keapstone Therapeutics IPO soon?
No public IPO plans have been announced for Keapstone Therapeutics.
How can I track Keapstone Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Keapstone Therapeutics's shares on secondary markets.